These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8005128)

  • 1. Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure.
    Sigurdsson A; Swedberg K; Ullman B
    Eur Heart J; 1994 Feb; 15(2):247-54. PubMed ID: 8005128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
    Sigurdsson A; Amtorp O; Gundersen T; Nilsson B; Remes J; Swedberg K
    Br Heart J; 1994 Nov; 72(5):422-7. PubMed ID: 7818958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure.
    Kato M; Kinugawa T; Omodani H; Osaki S; Ahmmed GU; Ogino K; Hisatome I; Miyakoda H; Thames MD
    J Card Fail; 1996 Jun; 2(2):103-10. PubMed ID: 8798111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ramipril on plasma atrial natriuretic peptide, antidiuretic hormone, angiotensin II and aldosterone in patients with chronic congestive heart failure.
    Heintz B; Verho M; Brockmeier D; Kirsten R; Nelson K; Rangoonwala B; Maigatter S; Lückel G; Kierdorf H; Sieberth HG
    Clin Physiol Biochem; 1992; 9(3):113-8. PubMed ID: 1302161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
    Ullman B; Lindvall K; Lundberg JM; Sigurdsson A; Swedberg K
    Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure.
    Clarkson PB; Wheeldon NM; MacFadyen RJ; Pringle SD; MacDonald TM
    Circulation; 1996 Jun; 93(11):2037-42. PubMed ID: 8640980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of atrial natriuretic peptide and of other vasoconstricting hormones in patients with chronic heart failure: relationship to exercise capacity.
    Chati Z; Mertès PM; Aliot E; Zannad F
    Int J Cardiol; 1996 Dec; 57(2):135-42. PubMed ID: 9013265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
    Kinugawa T; Osaki S; Kato M; Ogino K; Shimoyama M; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1060-5. PubMed ID: 12390293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure.
    de Groote P; Millaire A; Pigny P; Nugue O; Racadot A; Ducloux G
    J Heart Lung Transplant; 1997 Sep; 16(9):956-63. PubMed ID: 9322147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of effect on exercise capacity of 12-weeks treatment with ramipril in patients with moderate congestive heart failure. Ramipril Study Group.
    Gundersen T; Swedberg K; Amtorp O; Remes J; Nilsson B
    Eur Heart J; 1994 Dec; 15(12):1659-65. PubMed ID: 7698136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
    Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor.
    Kinugawa T; Ogino K; Kato M; Furuse Y; Shimoyama M; Mori M; Endo A; Kato T; Omodani H; Osaki S; Miyakoda H; Hisatome I; Shigemasa C
    Gen Pharmacol; 1998 Jul; 31(1):93-9. PubMed ID: 9595286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
    Berglund H; Nyquist O; Beermann B; Jensen-Urstad M; Theodorsson E
    Br Heart J; 1994 Dec; 72(6):521-7. PubMed ID: 7857733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide levels in congestive heart failure in man before and during converting enzyme inhibition.
    Crozier IG; Nicholls MG; Ikram H; Espiner EA; Yandle TG
    Clin Exp Pharmacol Physiol; 1989 May; 16(5):417-24. PubMed ID: 2527656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
    Sigurdsson A; Held P; Swedberg K; Wall B
    Eur Heart J; 1993 Aug; 14(8):1110-7. PubMed ID: 8404942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.